Mundipharma Launches Pegfilgrastim Biosimilar in Europe

Published date15 February 2019
Law FirmGoodwin
Subject MatterEU,Prescription Drugs,Biosimilars,Pharmaceutical Industry,European Medicines Agency (EMA)

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT